APA (7th ed.) Citation

Chen, B., Haste, N., Binkin, N., Law, N., Horton, L. E., Yam, N., . . . Abeles, S. (2023). Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era. PLoS ONE, 18(4), 1. https://doi.org/10.1371/journal.pone.0275356

Chicago Style (17th ed.) Citation

Chen, Benjamin, Nina Haste, Nancy Binkin, Nancy Law, Lucy E. Horton, Nancy Yam, Victor Chen, and Shira Abeles. "Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron Era." PLoS ONE 18, no. 4 (2023): 1. https://doi.org/10.1371/journal.pone.0275356.

MLA (9th ed.) Citation

Chen, Benjamin, et al. "Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron Era." PLoS ONE, vol. 18, no. 4, 2023, p. 1, https://doi.org/10.1371/journal.pone.0275356.